Is Dynatrace an American company?
Yes, Dynatrace, Inc. is an American multinational technology company. It is headquartered in Boston, Massachusetts, and provides an AI-powered observability and security platform. While it operates on a global scale, it is incorporated in the United States and trades on the New York Stock Exchange under the ticker symbol DT.
Related FAQs
No, Dyne Therapeutics (DYN) does not pay a dividend.
Dynex Capital operates as an internally managed real estate investment trust that generates income by financing residential and commercial real estate assets in the United States.
A single share of Eastern Bankshares, Inc. (NASDAQ: EBC) trades at approximately $22.92 USD, supported by a total corporate market capitalization of roughly $5.30 billion.
Assessing the share price volatility of Dynex Capital, Inc.—a mortgage real estate investment trust that invests in mortgage-backed securities—indicates a moderate volatility profile.
The ticker "DT" refers to Dynatrace Inc., a software-as-a-service company in the IT observability market.
Dynatrace is generally viewed very positively by both employees and the industry. It maintains an employee recommendation rate of approximately 79% and an overall rating of 4.1 out of 5 on major workplace review platforms.
The current market consensus for Dynatrace (DT) is a "Strong Buy," with over 90% of analysts rating the stock as bullish as of July 2026.
Yes, Dynatrace demonstrates strong financial health and profitability. As of early 2026, the company reported impressive margins, including a net margin of approximately 27.33% and an operating margin of 12.18%.
Market sentiment and management actions suggest that Dynatrace is considered undervalued by many investors.